CDTX today

$221.38+$0.06 (+0.03%)close Jan 6, 2026

Trend

—

Key levels

—

Latest news & SEC filings

No headlines in the last 90 days.

· Healthcare

Cidara Therapeutics, Inc. (CDTX)

$221.38+0.06 (+0.03%)
HOLDGrade: CRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
219.8220.2220.6221.0221.38Dec 2Dec 10Dec 18Dec 29
High221.41
Low221.25
Open221.32
Volume2.11M
Avg Vol970K
VWAP221.37
30d High221.38
30d Low219.35
30d Chg+0.93%
See full chart with real-time data

What Is the Price Target for CDTX?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $221.38Upside: +0.0%Confidence: 20%Method: No Coverage

Is CDTX a Buy or Sell Right Now?

44
Investability Score
HOLD12-18 months

Thesis

  • •Revenue growing -94.5% YoY with UNKNOWN trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CDTX.

Start Free Trial →

Is CDTX Overvalued or Undervalued?

Valuation Verdict

FAIR

Methods Used

P/B

Fair Value

$221.38

5

Moat Score

NONE

2/9

Piotroski Score

32.6

Altman Z-Score

What Is Smart Money Doing with CDTX?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

DISTRIBUTING

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

CDTX Growth Story

Revenue YoY

-94.5%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-409.52%

FCF Growth YoY

-670.2%

Revenue Trend

UNKNOWN

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Cidara Therapeutics, Inc. (CDTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...

Sign Up Free — Download AI Report PDF →

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

Compare SEPT with other platforms

SEPT vs TradingViewSEPT vs BloombergSEPT vs Unusual WhalesSEPT vs SpotGammaSEPT vs TrendSpiderAI Trading Platforms Compared
What is dark pool trading?How to read options flowGEX explainedSmart money trackingAI stock analysisEarn money on SEPT

About SEPT Investing

SEPT Investing tracks 13,000+ stocks with live charts, trend and key-level tracking, dark pool and options flow, insider and congress trades, SEC filings and news alerts.

Disclaimer: This page is for informational purposes only. It does not constitute financial advice. Past performance does not guarantee future results. Always do your own research before making investment decisions.

CDTX — frequently asked questions

What is CDTX stock price today?

Cidara Therapeutics, Inc. (CDTX) is at $221.38, up 0.03% (+$0.06) at the Jan 6, 2026 close.

Did CDTX beat earnings?

CDTX last reported on Nov 6, 2025: EPS -$3.10 vs -$1.34 expected — a miss of 131.3%.

Does CDTX pay a dividend?

CDTX does not currently pay a dividend.

What are insiders doing with CDTX?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.